Device Trial Radar · NCT07290426
Vbeam Pro Pulse Dye Laser for the Treatment of Vascular Conditions
Last checked: Nov 21, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
40
Planned (sponsor's estimate)
Start
Dec 10, 2025
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Candela CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 18, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a clinical study to evaluate the safety and performance of the Vbeam Pro Laser System for the treatment of vascular indications, including rosacea and port wine stain birthmarks.
Conditions
- Rosacea
- Vascular Diseases
- Port-Wine Stain
Interventions
Vbeam Pro Laser TreatmentDevice
Treatment with Vbeam Pro Laser System
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clearance of Vascular LesionTime frame: Baseline to Follow-up #1 (up to 72 weeks)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Candela European Institute for Excellence
Madrid, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.